GH Research
- Market cap
- 1.45B
- P/E (TTM)i
- -21.27
- P/Bi
- 4.02
- EPSi
- -0.79
- Div yieldi
- 0.00%
- 52W posi
- 46%
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
- Total institutional ownership fell 4.1 percentage points.
Institutional ownership
- Held by institutions
- 71.20% -4.07pp
- Institutions
- 72
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
AlignedInstitutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Top holders as of 2026-04-01
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
13 filings tracked · 4 buys · 0 sells
| Name | Role | Stake |
|---|---|---|
| Florian Schonharting | Co-Founder & Non-Executive Chairman of the Board | 21.60% |
| Magnus Halle | Co-Founder & MD of Ireland | 0.17% |
| Michael Forer | Independent Vice Chairperson | 0.07% |
| Duncan Moore | Independent Non-Executive Director | 0.02% |
| Dermot Hanley | Independent Non-Executive Director | 0.00% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-07 | Florian Schonharting | Co-Founder & Non-Executive Chairman of the Board | Other Derivative Acquisition | +2,303 | $0.03 |
| 2026-08-10 | Michael Forer | Independent Vice Chairperson | Other Derivative Acquisition | +102,202 | $0.03 |
| 2026-08-10 | Dermot Hanley | Independent Non-Executive Director | Other Derivative Acquisition | +2,202 | $0.03 |
| 2026-08-10 | Duncan Moore | Independent Non-Executive Director | Other Derivative Acquisition | +2,202 | $0.03 |
| 2026-03-31 | Florian Schonharting | Co-Founder & Non-Executive Chairman of the Board | Initial Statement of Beneficial | 0 | -- |
| 2026-03-17 | Michael Forer | Independent Vice Chairperson | Initial Statement of Beneficial | 0 | -- |
| 2026-03-17 | Dermot Hanley | Independent Non-Executive Director | Initial Statement of Beneficial | 0 | -- |
| 2026-03-17 | Duncan Moore | Independent Non-Executive Director | Initial Statement of Beneficial | 0 | -- |
| 2026-03-17 | Magnus Halle | Co-Founder & MD of Ireland | Initial Statement of Beneficial | 0 | -- |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 04:00:02 · For reference only, not investment advice and not tailored to your situation.